Active	Status	Sponsor type	Region	Phase	Filter
13 Active 6 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Feun, Lynn G
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma	Active, not recruiting	2	134	US, RoW	SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo	Coherus Biosciences, Inc.	Hepatocellular Carcinoma	05/25	05/26
NCT06627244: Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma	Recruiting	2	30	US	Tebentafusp, Tebentafusp-tebn, TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization, Y-90 TARE	University of Miami, Immunocore Ltd	Metastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver	02/28	02/31
NCT04109456: IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma	Active, not recruiting	1	120	US, RoW	IN10018, BI 853520, Cobimetinib, Cotellic, Atezolizumab	InxMed (Shanghai) Co., Ltd.	Metastatic Melanoma	06/25	12/25
Jayaweera, Dushyantha T
NCT05869643: A Clinical Trial of STP0404 in Adults with HIV-1 Infection	Recruiting	2	36	US	Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir), Placebo	ST Pharm Co., Ltd.	HIV-1-infection	12/25	12/25
NCT06061081: A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1	Suspended	2	26	Europe, US, RoW	VH3739937, Placebo	ViiV Healthcare	HIV Infections	11/24	11/24
Harton, Lisa
KEYNOTE-C16, NCT04374877: Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors	Recruiting	1	260	US, RoW	CHS-388, Casdozokitug, Pembrolizumab, Keytruda®, Toripalimab, Loqtorzi®	Coherus Biosciences, Inc., Merck Sharp & Dohme LLC	Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma, Non-small Cell Lung Cancer	12/25	08/26
Sanchez, Josefina
No trials found
Vidro, Mayra
No trials found